Epista Life Science

Investment Thesis

• The investment thesis is anchored in continued organic growth coupled with further internationalization via M&A.
• Organic growth is to be driven by targeted value propositions towards all types of life science customers ranging from mature pharma companies to biotech start-ups.
• M&A will be deployed to accelerate further international growth and a consolidation of similar niche focused IT services firms dedicated to the life science industry

Main Transformation Initiatives

• Further develop the organization for international growth
• Develop current service offerings
• Complement organic growth by pursuing strategic acquisitions